Michael Dudley is the founder of Qpex Biopharma. Qpex Biopharma has raised $165M in total funding. Latest round: Series A. Based in Cambridge, MA.
Michael Dudley is the Co-founder and Chief Executive Officer of Qpex Biopharma, a company established in 2018. He led the company's Series A financing round and the acquisition of preclinical programs from The Medicines Company. Dudley's work at Qpex Biopharma focuses on developing treatments for drug-resistant, gram-negative infections.
Full founder directory · Investor directory · Company funding database · Fundraising library